Despite a slight tendency (p = 0.06) toward higher serum levels of the chemokine SDF1α in the MetS and T2DM groups compared to the healthy lean group, a significant reduction was evident in the percentage of circulating HSCs within these two groups (Figure 3). The gene discussed is CXCL12; the disease is metabolic syndrome.